These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34720142)

  • 1. Is P&T Ready to Add Rapid Cycle Analytics to Formulary?
    Altshuler D; Yu K; Papadopoulos J; Dabestani A
    Hosp Pharm; 2021 Oct; 56(5):430-435. PubMed ID: 34720142
    [No Abstract]   [Full Text] [Related]  

  • 2. Inpatient Perioperative Formulary Restriction of Intravenous Acetaminophen at Vizient Partner Hospitals: A National Survey of Pharmacists.
    Wallskog KE; Lauderdale S; Peppard WJ; Kirkwood C; Taylor S; Johnston S
    Hosp Pharm; 2021 Dec; 56(6):650-659. PubMed ID: 34732917
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospitalization Costs for Patients Undergoing Orthopedic Surgery Treated With Intravenous Acetaminophen (IV-APAP) Plus Other IV Analgesics or IV Opioid Monotherapy for Postoperative Pain.
    Maiese BA; Pham AT; Shah MV; Eaddy MT; Lunacsek OE; Wan GJ
    Adv Ther; 2017 Feb; 34(2):421-435. PubMed ID: 27943118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The formulary decision-making process in a US academic medical centre.
    Nash DB; Catalano ML; Wordell CJ
    Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of pharmacoeconomic data in making hospital formulary decisions.
    Odedina FT; Sullivan J; Nash R; Clemmons CD
    Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in Formulary Management Practices Within the Department of Veterans Affairs Health Care System.
    Radomski TR; Good CB; Thorpe CT; Zhao X; Marcum ZA; Glassman PA; Lowe J; Mor MK; Fine MJ; Gellad WF
    J Manag Care Spec Pharm; 2016 Feb; 22(2):114-20. PubMed ID: 27015250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulary management in the Department of Defense.
    Trice S; Devine J; Mistry H; Moore E; Linton A
    J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From a to z: medication cost-management strategies for disproportionate share hospitals.
    Henry A; Erowele GI; Ndefo UA; Milton-Brown J; Anassi E; Green W; Alvidrez A; Okpara AU
    Am Health Drug Benefits; 2011 May; 4(3):172-80. PubMed ID: 25126349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a formulary management process.
    Karel LI; Delisle DR; Anagnostis EA; Wordell CJ
    Am J Health Syst Pharm; 2017 Aug; 74(16):1245-1252. PubMed ID: 28790076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transparency in evidence evaluation and formulary decision-making: from conceptual development to real-world implementation.
    Dean BB; Ko KJ; Graff JS; Localio AR; Wade R; Dubois RW
    P T; 2013 Aug; 38(8):465-83. PubMed ID: 24222979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulary evaluation using a class review approach: experience and results from an academic medical center.
    Persson EL; Miller KS; Nieman JA; Sgourakis AP; Akkerman SR
    P T; 2013 Apr; 38(4):213-6. PubMed ID: 23785226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing an efficient scheduling template of a chemotherapy treatment unit: A case study.
    Ahmed Z; Elmekkawy T; Bates S
    Australas Med J; 2011; 4(10):575-88. PubMed ID: 23386870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Intravenous Acetaminophen on Post-Anesthesia Care Unit Length of Stay, Opioid Consumption, Pain, and Analgesic Drug Costs After Ambulatory Surgery.
    Khobrani MA; Camamo JM; Patanwala AE
    P T; 2017 Feb; 42(2):125-139. PubMed ID: 28163558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of pharmacoeconomics to formulary management in a health system setting.
    Studdert AL; Gong CL; Srinivas S; Chin AL; Deresinski S
    Am J Health Syst Pharm; 2019 Feb; 76(6):381-386. PubMed ID: 31361838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
    Spooner JJ; Gandhi PK; Connelly SB
    J Manag Care Pharm; 2007; 13(1):37-43. PubMed ID: 17269835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.